{"nct_id":"NCT02207816","title":"An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2014-09-18","start_date_type":"ACTUAL","primary_completion_date":"2017-01-31","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}